Dianthus Therapeutics (DNTH) Change in Acquisitions & Divestments (2019 - 2025)

Dianthus Therapeutics' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $78.6 million for Q3 2025.

• In Q3 2025, Change in Acquisitions & Divestments rose 313.53% year-over-year to $78.6 million; the TTM figure through Sep 2025 stood at $305.3 million (up 408.86% YoY), while the FY2024 annual figure was $127.0 million, up 63.27% from the prior year.
• Change in Acquisitions & Divestments for Q3 2025 stood at $78.6 million, up from $59.6 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $85.0 million in Q4 2024, with the low at $2.0 million in Q4 2022.
• The 5-year median for Change in Acquisitions & Divestments is $20.4 million (2023), against an average of $32.3 million.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments tumbled 94.29% in 2022, then jumped 800.0% in 2023.
• Dianthus Therapeutics' Change in Acquisitions & Divestments stood at $35.0 million in 2021, then sank by 94.29% to $2.0 million in 2022, then surged by 800.0% to $18.0 million in 2023, then jumped by 372.22% to $85.0 million in 2024, then fell by 7.56% to $78.6 million in 2025.
• Business Quant data shows DNTH's Change in Acquisitions & Divestments at $78.6 million in Q3 2025, $59.6 million in Q2 2025, and $82.1 million in Q1 2025.